
Sign up to save your podcasts
Or
In this episode we welcome Dr. Didem Saygin, a rheumatology fellow from the University of Chicago, to the podcast. We are also joined by Dr. Guy Katz, a rheumatology fellow from MGH. We discuss three more topics that would be excellent teams in the upcoming RheumMadness tournament: the newly discovered VEXAS autoinflammatory syndrome, the FAST trial on cardiovascular safety of urate-lowering therapies, and the PEXIVAS trial in ANCA vasculitis.
New RheumMadness website!
https://sites.duke.edu/rheummadness/
References:
VEXAS: https://www.nejm.org/doi/full/10.1056/NEJMoa2026834
FAST: https://www.thelancet.com/article/S0140-6736(20)32234-0/fulltext
PEXIVAS: https://www.nejm.org/doi/full/10.1056/NEJMoa1803537
RheumMadness Music Attribution: Cheery Monday by Kevin MacLeod
Link: https://incompetech.filmmusic.io/song/3495-cheery-monday
License: http://creativecommons.org/licenses/by/4.0/
4.9
1111 ratings
In this episode we welcome Dr. Didem Saygin, a rheumatology fellow from the University of Chicago, to the podcast. We are also joined by Dr. Guy Katz, a rheumatology fellow from MGH. We discuss three more topics that would be excellent teams in the upcoming RheumMadness tournament: the newly discovered VEXAS autoinflammatory syndrome, the FAST trial on cardiovascular safety of urate-lowering therapies, and the PEXIVAS trial in ANCA vasculitis.
New RheumMadness website!
https://sites.duke.edu/rheummadness/
References:
VEXAS: https://www.nejm.org/doi/full/10.1056/NEJMoa2026834
FAST: https://www.thelancet.com/article/S0140-6736(20)32234-0/fulltext
PEXIVAS: https://www.nejm.org/doi/full/10.1056/NEJMoa1803537
RheumMadness Music Attribution: Cheery Monday by Kevin MacLeod
Link: https://incompetech.filmmusic.io/song/3495-cheery-monday
License: http://creativecommons.org/licenses/by/4.0/
131 Listeners
325 Listeners
133 Listeners
61 Listeners
124 Listeners
17 Listeners
3,336 Listeners
1,095 Listeners
117 Listeners
5,060 Listeners
120 Listeners
519 Listeners
349 Listeners
69 Listeners
12 Listeners
63 Listeners
366 Listeners
172 Listeners
0 Listeners
17 Listeners
2 Listeners